Korro Bio, Inc. (KRRO)
7.86
+0.03
(+0.38%)
USD |
NASDAQ |
Dec 11, 16:00
7.60
-0.26
(-3.31%)
After-Hours: 18:17
Korro Bio EPS Diluted (Quarterly): -1.923 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Nutriband, Inc. | -2.123 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.06M |
| Revenue (Quarterly) | 1.09M |
| Total Expenses (Quarterly) | 19.15M |
| Enterprise Value | 24.93M |
| Gross Profit Margin (Quarterly) | -10.09% |
| Profit Margin (Quarterly) | -1.66K% |
| Earnings Yield | -119.8% |
| Normalized Earnings Yield | -119.85 |